BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 32.94
+1.11 (3.49%)
At close: Jul 31, 2026
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 14.34 billion as of July 31, 2026. Its market cap has decreased by -66.06% in one year.
Market Cap
14.34B
Enterprise Value
16.40B
Revenue
1.30B
Ranking
n/a
PE Ratio
276.95
Stock Price
32.94
ChartMarket Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 14.34B, an increase of 14.24%. That is a compound annual growth rate of 2.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 14.34B | -30.87% |
| Dec 31, 2025 | 20.74B | 62.70% |
| Dec 31, 2024 | 12.75B | -13.79% |
| Dec 29, 2023 | 14.79B | 55.07% |
| Dec 30, 2022 | 9.54B | -36.65% |
| Dec 31, 2021 | 15.05B | -19.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yili Chuanning Biotechnology | 19.47B |
| Sinocelltech Group | 15.92B |
| Jinyu Bio-technology | 13.81B |
| Anhui Anke Biotechnology (Group) | 13.77B |
| Mabwell (Shanghai) Bioscience | 12.28B |
| Inner Mongolia Furui Medical Science | 11.98B |
| Tibet Cheezheng Tibetan Medicine | 11.89B |
| InventisBio | 11.66B |